Program

Day :1

5 th July, 2024 (Friday)

Hall - A

07:00AM - 08:00AM
Registration & Breakfast
08:00AM - 09:00AM Breakfast Symposium Session Sponsor Glenmark
Moderators:
user

Ajoy Biswas

(Kolkata)

08:00AM - 08:18AM

user

Tejas Shah

(Mumbai)
RECORD Registry: Insights from the Indian Hypertension registry

08:20AM - 08:38AM

user

Anil Virmani

(Jamshedpur)
Harnessing gluco-metabolic benefits of Sitagliptin based triple fixed dose combinations in evolving landscape of type 2 diabetes management

08:40AM - 08:58AM

user

Jayant Panda

(Cuttack)
Targeting Diabesity with Biosimilar Liraglutide
user

Kaushik Munshi

(Kolkata)
09:00AM - 09:30AM
Inauguration
09:30AM - 12:30PM
Workshop in Hall BSR 1, 2, 4 and 5
09:30AM - 12:30PM
Quiz for Industry participants : Biswajit Ghosh Dastidar & Ajoy Biswas
12:30PM - 01:00PM
Audience Quiz
Sudip Chatterjee (Kolkata)
12:00PM - 03:00PM
No session break for lunch (Have lunch at your convenience at Eastern court)
01:00PM - 01:50PM Bariatric Surgery, Nutrition and Diabetes Management
Chairpersons:
user

Sujoy Majumdar

(Kolkata)

01:00PM - 01:20PM

user

Subodh Banzal

(Indore)
Long term management of a person with T2DM post bariatric surgery

01:20PM - 01:40PM

user

Mala Dharmalingam

(Bengaluru)
Nutritional supplements in T2DM does it matter?

01:40PM - 01:50PM

Panel-Discussion
Panel Discussion
user
Arindam Naskar
(Kolkata)
01:50PM - 02:40PM Controversies in Diabetes Session Sponsor Glenmark
Chairpersons:
user

Shalini Jaggi

(New Delhi)

01:50PM - 02:10PM

user

Rajeev Chawla

(New Delhi)
Pre pregnancy planning in T2 DM

02:10PM - 02:30PM

user

Sunil Gupta

(Nagpur)
Non insulin therapy of hyperglycaemia in pregnancy

02:30PM - 02:40PM

Panel-Discussion
Panel Discussion
user

Mary D`cruz

(Kolkata)
02:40PM - 03:30PM Debate 01: Best Gliptin Session Sponsor MSD & Boehringer Ingelheim
Chairpersons:
user

K. K. Gangopadhyay

(Kolkata)

02:40PM - 03:00PM

user

H. N. Chakravarti

(Kolkata)
Best Gliptin Sitagliptin

03:00PM - 03:20PM

user

Sunetra Mondal

(Kolkata)
Best Gliptin Linagliptin

03:20PM - 03:30PM

Panel-Discussion
Panel Discussion
user

Sanjay Shrivastava

(Jamshedpur)
03:30PM - 04:20PM Mental Health & Diabetes Session Sponsor Alteus
Chairpersons:
user

Biswajit Ghosh Dastidar

(Kolkata)

03:30PM - 03:50PM

user

A. H. Zargar

(Srinagar)
Recognising depression in diabetes

03:50PM - 04:10PM

user

Arpandev Bhattacharyya

(Bengaluru)
Managing diabetes in patients with dementia

04:10PM - 04:20PM

Panel-Discussion
Panel Discussion
user

Sanjay Garg

(Kolkata)
04:20PM - 05:10PM Kidney Health & Diabetes
Chairpersons:
user

Arup Ratan Dutta

(Kolkata)

04:20PM - 04:40PM

user

Suresh Damodaran

(Coimbatore)
Preventing DKD beyond RAASB and SGLT2i

04:40PM - 05:00PM

user

Upal Sengupta

(Kolkata)
Non diabetic kidney disease in T2DM

05:00PM - 05:10PM

Panel-Discussion
Panel Discussion
user

Kaushik Saha

(Kolkata)
05:10PM - 06:10PM Industry Symposium : USV
Chairpersons:
user

Debasis Maji

(Kolkata)

05:10PM - 05:25PM

user

Banshi Saboo

(Ahmedabad)
Modern SU + Metformin: Sustainable Kingpins of OADs

05:25PM - 05:40PM

user

J. J. Mukherjee

(Kolkata)
SGLT2i as a First Line Antihyperglycemic Agent in T2DM in the Indian Context

05:40PM - 05:55PM

user

Brij Mohan

(Kanpur)
Insulin Aspart: India's Journey Towards Biosimilar Excellence
user

Samir Dasgupta

(Kolkata)

05:55PM - 06:10PM

Panel-Discussion
Panel Discussion
06:10PM - 07:10PM Industry Symposium : Torrent
Chairpersons:
user

Sanjay Chatterjee

(Kolkata)

06:10PM - 06:25PM

user

Amitabh Sur

(Kolkata)
Met/SGLT2i/ DPP4i in the Indian context

06:25PM - 06:40PM

user

Anirban Majumder

(Kolkata)
Tackling PP glucose with OHA beyond SU

06:40PM - 06:55PM

user

Ipsita Mishra

(Cuttack)
Positioning Imeglimin in current T2DM management
user

Bijay Patni

(Kolkata)

06:55PM - 07:10PM

Panel-Discussion
Panel Discussion
07:10PM - 08:10PM Industry Symposium : Sanofi
Chairpersons:
user

Alok Kanungo

(Bhubaneswar)

07:10PM - 07:25PM

user

Subir Ray

(Kolkata)
Patient centric approach with basal insulin

07:25PM - 07:40PM

user

Sachin Mittal

(Chandigarh)
Combining efficacy with simplicity for T2D management

07:40PM - 07:55PM

user

Jothydev Kesavadev

(Thiruvananthapuram)
Paradigm shift in T2DM management with combination injectable of iGlarLixi
user

Ghanshyam Goyal

(Kolkata)

07:55PM - 08:10PM

Panel-Discussion
Panel Discussion
08:10PM - 09:10PM Industry Symposium : Boehringer Ingelheim
Chairpersons:
user

Sekhar Chakroborty

(Siliguri)

08:10PM - 08:30PM

user

A. G. Unnikrishnan

(Pune)
Positioning SGLT2i+ DPP4i in T2DM management

08:30PM - 08:50PM

user

Rajasekara Chakravarthi

(Hyderabad)
Renal-Metabolic Risk Reduction in T2DM

08:50PM - 09:10PM

Panel-Discussion
Panel Discussion
user

J. J. Mukherjee

(Kolkata)
09:10PM - 10:00PM
Working Dinner in Hall B

Hall - B

01:00PM - 01:50PM Session 1
Chairpersons:
user

Masood Batin

(Kolkata)

01:00PM - 01:20PM

user

Swyamsidha Mangaraj

(Bhubaneshwar)
Elevated serum triglycerides-to treat or not to treat-what is the evidence?

01:20PM - 01:40PM

user

Partha Pratim Chakraborty

(Kolkata)
What is the LDLC target in different risk groups? How best to achieve that target?

01:40PM - 01:50PM

Panel-Discussion
Panel Discussion
user

J. B. Kanwar

(Bhubaneshwar)
01:50PM - 02:40PM Session 2
Chairpersons:
user

Anirban Majumder

(Kolkata)

01:50PM - 02:10PM

user

J. B. Kanwar

(Bhubaneshwar)
Approach to a 22-yr-old female presenting with tetany and a corrected serum calcium value of 4.8 mg/dL

02:10PM - 02:30PM

user

Pradip Mukherjee

(Kolkata)
Approach to a 22-yr-old ambulatory hypertensive male with a corrected serum calcium value of 13.5 mg/dL

02:30PM - 02:40PM

Panel-Discussion
Panel Discussion
user

Santosh Kumar Singh

(Patna)
02:40PM - 03:30PM Session 3
Chairpersons:
user

Debasis Maji

(Kolkata)

02:40PM - 03:00PM

user

Binayak Sinha

(Kolkata)
Approach to a 24-year-old female (BMI 28) with hirsutism (periods regular/no galactorrhea)

03:00PM - 03:20PM

user

Belinda George

(Bengaluru)
Approach to a 28-year-old female (BMI 28) with irregular periods and a 9 AM follicular phase 17-OHP of 300 ng/dL

03:20PM - 03:30PM

Panel-Discussion
Panel Discussion
user

V. Sri Nagesh

(Hyderabad)
03:30PM - 04:20PM Session 4
Chairpersons:
user

Ghanshyam Goyal

(Kolkata)

03:30PM - 03:50PM

user

Santosh Kumar Singh

(Patna)
What to assess and how to initiate THYROXINE replacement therapy in a 65-yr-old with FT4 0.2 ng/dL and TSH 128 uIU/mL

03:50PM - 04:10PM

user

Nilanjan Sengupta

(Kolkata)
Should we use T3+T4 in the management of primary hypothyroidism? An evidence based deliberation

04:10PM - 04:20PM

Panel-Discussion
Panel Discussion
user

R. K. Saraogi

(Kolkata)
04:20PM - 05:10PM Session 5
Chairpersons:
user

Subir Ray

(Kolkata)

04:20PM - 04:40PM

user

V. Sri Nagesh

(Hyderabad)
USG of a thyroid nodule: what's expected in a complete report? How to interpret it?

04:40PM - 05:00PM

user

Kaushik Pandit

(Kolkata)
FNAC of a thyroid nodule: what's expected in a complete report? How to interpret it?

05:00PM - 05:10PM

Panel-Discussion
Panel Discussion
user

Salil Pal

(Kolkata)
Industry Symposium in Hall A